Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03176927 · ClinicalTrials.gov registry record · Early Phase 1
Biomagnetic Characterization of Gastric Dysrhythmias III
A Early Phase 1 study of Functional Dyspepsia and Diabetic Gastroparesis, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT03176927: Completed Early Phase 1 study of Functional Dyspepsia and Diabetic Gastroparesis, sponsored by Vanderbilt University Medical Center.
NCT03176927 is a Early Phase 1 study of Functional Dyspepsia and Diabetic Gastroparesis that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 22 participants, below the 70-participant average among 9 other Functional Dyspepsia trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03176927, a Early Phase 1 study of Functional Dyspepsia and Diabetic Gastroparesis, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
There is a tremendous clinical need for a noninvasive technique that can assess gastric electrical activity and would be repeatable without any exposure to radiation. Investigators developed a new technique allowing to use noninvasive methods to assess bioelectrical activity in the gastrointestinal system. This has enabled to characterize the normal and pathologic physiology of the stomach through the use of noninvasive magnetogastrogram (MGG) records. Primary hypothesis for this proposal is that analysis of gastric slow wave uncoupling and propagation in multichannel MGG discriminates between normal and pathological gastric electrical activity. Eventually, investigators envision this research leading to new insights for gastrointestinal conditions such as gastroparesis, functional dyspepsia and chronic idiopathic nausea that would inform clinical management of these debilitating diseases.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST magnetogastrogram
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2012-12 |
| Est. Completion | 2025-05-12 |
| Phase | Early Phase 1 |
What the finished NCT03176927 record still lists
NCT03176927 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 70-participant average among 9 other Functional Dyspepsia trials with a reported enrollment target (69% lower).
The record links to 6 conditions, with Functional Dyspepsia appearing as the primary indexed condition, and to 1 intervention - of which magnetogastrogram is the first listed.
NCT03176927 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT03176927 about?
NCT03176927 is a clinical study titled "Biomagnetic Characterization of Gastric Dysrhythmias III". There is a tremendous clinical need for a noninvasive technique that can assess gastric electrical activity and would be repeatable without any exposure to radiation. Investigators developed a new technique allowing to use noninvasive methods to assess bioelectrical activity in the gastrointestinal ...
What is the current status of trial NCT03176927?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 22 participants. The study started on 2012-12. Estimated completion is 2025-05-12.
What conditions does trial NCT03176927 study?
This clinical trial studies the following conditions: Functional Dyspepsia, Diabetic Gastroparesis, Idiopathic Gastroparesis, Diabetics Without Symptoms of Gastroparesis, Total or Partial Gastrectomy.
What interventions are being tested in trial NCT03176927?
The interventions under investigation include: magnetogastrogram (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03176927?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03176927 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Functional Dyspepsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03176927's enrollment target sits among peer trials
22 8th of 9 higher than 2 of 9 other Functional Dyspepsia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Functional Dyspepsia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Synergistic Gut-brain Axis Modulation Via Vagal Stimulation and Support Therapy in Functional Dyspepsia
RECRUITING · NA
-
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
RECRUITING · NA
-
Ketotifen for Children With Functional Dyspepsia in Association With Duodenal Eosinophilia
RECRUITING · Phase 3
-
Autonomic Reactivity and Personalized Neurostimulation
RECRUITING · NA
-
Functional Dyspepsia Treatment Using Virtual Reality
RECRUITING · NA
-
Brain-Gut Yoga for Functional Dyspepsia and Gastroparesis (FD-GP)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia